From owner-diagnost@hgmp.mrc.ac.uk Tue Feb 8 15:47:18 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id 793FF17BBC; Tue, 8 Feb 2000 15:47:16 +0000 (GMT) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 1) id BE0F117A85; Tue, 8 Feb 2000 15:47:11 +0000 (GMT) To: diagnost@net.bio.net Newsgroups: bionet.diagnostics From: daemon@hgmp.mrc.ac.uk, [mailto:daemon@hgmp.mrc.ac.uk]@hgmp.mrc.ac.uk, On@hgmp.mrc.ac.uk, Behalf@hgmp.mrc.ac.uk, Of@hgmp.mrc.ac.uk Subject: DGGE Message-Id: <20000208154711.BE0F117A85@mercury.hgmp.mrc.ac.uk> Date: Tue, 8 Feb 2000 15:47:11 +0000 (GMT) Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk ihave some difficulties with performing a DGGE method to dignose the alpha thalassemia poit mutations. can you help me thank you --- From owner-diagnost@hgmp.mrc.ac.uk Wed Feb 9 09:18:19 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id 625CF17BAB; Wed, 9 Feb 2000 09:18:18 +0000 (GMT) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 1) id 82FFD17AEC; Wed, 9 Feb 2000 09:18:16 +0000 (GMT) To: diagnost@net.bio.net Newsgroups: bionet.diagnostics From: Stacy@hgmp.mrc.ac.uk, Ciufo@hgmp.mrc.ac.uk, [mailto:ciufo@murex.micro.umass.edu]@hgmp.mrc.ac.uk Subject: Re: DGGE Message-Id: <20000209091816.82FFD17AEC@mercury.hgmp.mrc.ac.uk> Date: Wed, 9 Feb 2000 09:18:16 +0000 (GMT) Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk Hello, Maybe I could help if you tell me some specific problems you are having. Stacy Ciufo Molecular Biology Services Dept. of Microbiology University of Massaachusetts Amherst, MA 01003 sciufo@microbio.umass.edu daemon@hgmp.mrc.ac.uk [mailto:daemon@hgmp.mrc.ac.uk] On Behalf Of writes: > > ihave some difficulties with performing a DGGE method to dignose the > alpha thalassemia poit mutations. can you help me thank you > > > --- From owner-diagnost@hgmp.mrc.ac.uk Wed Feb 9 12:49:51 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id A03D917BE1; Wed, 9 Feb 2000 12:49:50 +0000 (GMT) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 1) id A770E17A5F; Wed, 9 Feb 2000 12:49:48 +0000 (GMT) To: diagnost@net.bio.net Newsgroups: bionet.diagnostics From: daemon@hgmp.mrc.ac.uk, [mailto:daemon@hgmp.mrc.ac.uk]@hgmp.mrc.ac.uk, On@hgmp.mrc.ac.uk, Behalf@hgmp.mrc.ac.uk, Of@hgmp.mrc.ac.uk Subject: detection of viable moulds on RNA basis Message-Id: <20000209124948.A770E17A5F@mercury.hgmp.mrc.ac.uk> Date: Wed, 9 Feb 2000 12:49:48 +0000 (GMT) Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk Does anybody know the half life time of free ribosomal DNA in a neutral solution? My idea is to detect in a quantitive way the amount of viable moulds on basis of RNA. The idea is that RNA has a short half life and therefor a RT PCR of freshly isolated total RNA could tell something about the number of viable cells. However I am not sure about the stability of ribosomal RNA. Edwin --- From owner-diagnost@hgmp.mrc.ac.uk Wed Feb 9 16:55:08 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id 025F617C07; Wed, 9 Feb 2000 16:55:02 +0000 (GMT) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 1) id 228FE17A5F; Wed, 9 Feb 2000 16:54:57 +0000 (GMT) To: diagnost@net.bio.net Newsgroups: bionet.diagnostics From: daemon@hgmp.mrc.ac.uk, [mailto:daemon@hgmp.mrc.ac.uk]@hgmp.mrc.ac.uk, On@hgmp.mrc.ac.uk, Behalf@hgmp.mrc.ac.uk, Of@hgmp.mrc.ac.uk Subject: fungal dna from human nails Message-Id: <20000209165457.228FE17A5F@mercury.hgmp.mrc.ac.uk> Date: Wed, 9 Feb 2000 16:54:57 +0000 (GMT) Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk Hi everybody, I am looking for a protocol to extract fungal DNA from human nails or skin (i.e, the keratinized tissue). Does anybody know how to release the fungal cells and get rid of the keratin. thanks YATIKA KOHLI, Ph.D. Clinical Microbiology Associate Dept of Microbiology Hospital of Sick Children Toronto, Ontario e-mail: kohliy@hotmail.com ______________________________________________________ Get Your Private, Free Email at http://www.hotmail.com --- From owner-diagnost@hgmp.mrc.ac.uk Mon Feb 14 09:26:42 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id 7C57617AD3; Mon, 14 Feb 2000 09:26:41 +0000 (GMT) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 1) id C57FF17A99; Mon, 14 Feb 2000 09:26:39 +0000 (GMT) To: diagnost@net.bio.net Newsgroups: bionet.diagnostics From: Oliver@hgmp.mrc.ac.uk, Scharnefski@hgmp.mrc.ac.uk, [mailto:O.Scharnefski@t-online.de]@hgmp.mrc.ac.uk Subject: HELP! Clinical research Message-Id: <20000214092639.C57FF17A99@mercury.hgmp.mrc.ac.uk> Date: Mon, 14 Feb 2000 09:26:39 +0000 (GMT) Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk Hello, I am in clinical research and need help to create a patient diary card for an enquiry. Do you have examples or sources where I may find them? Thank you very much. Oliver Scharnefski O.Scharnefski@t-online.de From owner-diagnost@hgmp.mrc.ac.uk Mon Feb 14 09:32:11 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id 26E8717AD4; Mon, 14 Feb 2000 09:32:11 +0000 (GMT) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 1) id E7FFD17AD3; Mon, 14 Feb 2000 09:32:09 +0000 (GMT) To: diagnost@net.bio.net Newsgroups: bionet.diagnostics From: daemon@hgmp.mrc.ac.uk, [mailto:daemon@hgmp.mrc.ac.uk]@hgmp.mrc.ac.uk, On@hgmp.mrc.ac.uk, Behalf@hgmp.mrc.ac.uk, Of@hgmp.mrc.ac.uk Subject: METMBS'2000 Call for Papers Message-Id: <20000214093209.E7FFD17AD3@mercury.hgmp.mrc.ac.uk> Date: Mon, 14 Feb 2000 09:32:09 +0000 (GMT) Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk The 2000 International Conference on Mathematics and Engineering Techniques in Medicine and Biological Sciences (METMBS'2000) June 26 - 29, 2000 Monte Carlo Resort, Las Vegas, Nevada, USA Call for Papers Recent advances in computer technology have provided the tools and the environment to study, analyze, and better understand complex systems. This technological development has enabled researchers to collect and analyze massive amounts of data to a scale previously not possible. The impact of this technology is now being felt in the medical field and in the biological sciences. In recent years, research in interdisciplinary areas such as Bioinformatics and computer assisted medical decision-making has dramatically intensified. METMBS'2000 aims to provide a platform for researchers to present and discuss recent breakthroughs in this area. The METMBS'2000 Conference will be held concurrently (i.e., same location and dates) with the International Conference on Parallel and Distributed Processing Techniques and Applications (PDPTA'2000), the International Conference on Imaging Science, Systems, and Technology (CISST) and the International Conference on Artificial Intelligence (IC-AI). You are invited to submit a draft paper of about 4 pages and/or a proposal to organize a technical session (see below for submission information). All accepted papers will be published in the conference proceedings. THE NAMES OF TECHNICAL SESSION CHAIRS WILL APPEAR AS ASSOCIATE EDITORS ON THE COVER OF THE CONFERENCE PROCEEDINGS. SCOPE Topics of interest include, but are not limited to, the following: o Bioinformatics: This includes informatics techniques in genomics gene sequencing, gene pattern discovery, gene pattern-function studies, and other genomics related studies). o Data mining in medicine and biological sciences. o Pattern recognition in medicine and biological sciences. o Signal processing in medicine and biological sciences (e.g. biomedical signal processing, etc.) o Image processing in medicine and biological sciences (e.g. biomedical image processing, biomedical imaging, etc.) o Medical decision-making. o Medical Physics. o Biomedical Engineering. o Biomedical Electronics. o Biosignal interpretation. o Any application of computers in Medicine and biological sciences (protein structure-function analysis, drug and protein design, molecular modeling and simulation, etc.) o Application of information technology in biomedicine (e.g. medical database management, information retrieval and use of computers in hospitals) o Application of Computational Intelligence (artificial neural networks, fuzzy logic, and evolutionary computing) in medicine and biological sciences o Medical and bio-computing. o Computer-based medical systems (automation in medicine, etc.) o Recent history (1990-1999) of Mathematics and engineering techniques in medicine and biological sciences, and what to expect during the next decade (2000-2009); New horizons. Review articles) o Other aspects and applications relating to technological advancements in medicine and biological sciences. SUBMISSION OF PAPERS Prospective authors are invited to submit three copies of their draft paper (about 4 pages) to F. Valafar (address is given below) by February 28, 2000. E-mail and Fax submissions are also acceptable. The length of the Camera-Ready papers (if accepted) will be limited to 7 pages. Papers must not have been previously published or currently submitted for publication elsewhere. The first page of the draft paper should include: title of the paper, name, affiliation, postal address, E-mail address, telephone number, and Fax number for each author. The first page should also include the name of the author who will be presenting the paper (if accepted) and a maximum of 5 keywords. PROPOSAL FOR ORGANIZING TECHNICAL SESSIONS Each technical session will have at least 6 paper presentations. The session chairs will be responsible for all aspects of their sessions, including soliciting papers, reviewing, selecting, ... The names of session chairs will appear as Associate Editors in the conference proceedings. After the conference, some sessions will be considered for publication in appropriate journals as Special Issues with the session proposer as the Guest Editor of the journal. Proposals to organize technical sessions should include the following information: name and address (+ E-mail) of the proposer, title of session, a 100-word description of the topic of the session, and a short description on how the session will be advertised (in most cases, session proposers solicit papers from colleagues and researchers whose work is known to the session proposer). Mail your proposal to F. Valafar (address is given below); E-mail submissions are preferred. EVALUATION PROCESS Papers will be evaluated for originality, significance, clarity, and soundness. Two researchers in the topical area will referee each paper. The Camera-Ready papers will be reviewed by one person. PUBLICATION The conference proceedings will be published by CSREA Press (ISBN). The proceedings will be available at the conference. Some accepted papers will also be considered for journal publication (soon after the conference). ORGANIZERS/SPONSORS A number of university faculty members and their staff, in cooperation with the Monte Carlo Resort (Conference Division, Las Vegas), will be organizing the conference. The conference will be sponsored by Computer Science Research, Education, & Applications Press (CSREA: USA Federal EIN # 58-2171953) in cooperation with research centers, international associations, international research groups, and developers of high-performance machines and systems. The complete list of sponsors and co-sponsors will be available at a later time. The last conference's sponsors included: CSREA, the National Supercomputing Center for Energy and the Environment - DOE, The International Association for Mathematics and Computers in Simulation, The International Technology Institute (ITI), The Java High Performance Computing research group, Korea Information Processing Society, World Scientific and Engineering Society, Sundance Digital Signal Processing Inc., the Computer Vision Research and Applications Tech., and more. LOCATION OF CONFERENCE The conference will be held in the Monte Carlo Resort Hotel, Las Vegas, Nevada, USA. This is a mega hotel with excellent conference facilities and over 3000 rooms. The hotel is minutes from the Las Vegas airport with free shuttles to and from the airport. This hotel has many vacation and recreational attractions, including: waterfalls, casino, spa, pools & kiddie pools, sunning decks, Easy River water ride, wave pool with cascades, lighted tennis courts, health spa (with workout equipment, whirlpool, sauna, ...), arcade virtual reality game rooms, nightly shows, snack bars, a number of restaurants, shopping area, bars, ... Many of these attractions are open 24 hours a day and most are suitable for families and children. The negotiated hotel's room rate for conference attendees is very reasonable ($79 + tax) per night (no extra charge for double occupancy) for the duration of the conference. The hotel is within walking distance from most other Las Vegas attractions (major shopping areas, recreational destinations, fine dining and night clubs, free street shows, and more). For the benefit of our international colleagues: the state of Nevada neighbors with the states of California, Oregon, Idaho, Utah, and Arizona. Las Vegas is only a few driving hours away from other major cities and attractions, including: Los Angeles, San Diego, Phoenix, the Grand Canyon, and more. EXHIBITION An exhibit is planned for the duration of the conference. We have reserved 20+ exhibit spaces. Interested parties should contact F. Valafar (address is given below). All exhibitors will be considered to be the co-sponsors of the conference. IMPORTANT DATES February 28, 2000 (Monday): Draft papers (about 4 pages) due April 3, 2000 (Monday): Notification of acceptance May 1, 2000 (Monday): Camera-Ready papers & Prereg. due June 26 - 29, 2000: PDPTA'2000 Conference Proposals to organize technical sessions should be submitted as soon as possible. All accepted papers are expected to be presented at the conference. MEMBERS OF PROGRAM & ORGANIZING COMMITTEES The Program Committee is currently being formed. Those interested in joining the Program Committee should e-mail F. Valafar (faramarz@cns.bu.edu ) the following information: Name, affiliation and position, complete mailing address, e-mail address, tel/fax numbers, a short biography together with research interests. OTHER INFORMATION Last year PDPTA, CISST, and IC-AI had research contributions from over 44 countries (over 900 participants from all over the world.) To make this a more complete suite of conferences, we have added METMBS. METMBS will also have a strong international flavor and offers its participants an introduction to a wide range of related interdisciplinary subjects through the other three conferences. CONFERENCE CONTACT: Faramarz Valafar Cognitive and Neural Systems Boston University 677 Beacon Street Boston, MA 02215 Tel: (617) 353-5134 Fax: (617) 353-7755 E-mail: Faramarz@cns.bu.edu --- --- From owner-diagnost@hgmp.mrc.ac.uk Thu Feb 17 09:10:44 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id EA84417ACD; Thu, 17 Feb 2000 09:10:43 +0000 (GMT) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 1) id 017F317A8B; Thu, 17 Feb 2000 09:10:42 +0000 (GMT) To: diagnost@net.bio.net Newsgroups: bionet.diagnostics From: daemon@hgmp.mrc.ac.uk, [mailto:daemon@hgmp.mrc.ac.uk]@hgmp.mrc.ac.uk, On@hgmp.mrc.ac.uk, Behalf@hgmp.mrc.ac.uk, Of@hgmp.mrc.ac.uk Subject: Antibody interactions Message-Id: <20000217091042.017F317A8B@mercury.hgmp.mrc.ac.uk> Date: Thu, 17 Feb 2000 09:10:42 +0000 (GMT) Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk -----Original Message----- From: Robert Burns [mailto:burns@sasa.gov.uk] Sent: 16 February 2000 11:36 To: diagnost@net.bio.net Subject: Antibody interactions We have come across a curious phenomenon when making cocktails of monoclonals. Two of our mab/Alk.phos conjugates which detect Potato Virus A pick up an isolate of this virus individually in ELISA. However when a mixture of the two conjugates is used we cannot detect this isolate. Any ideas of what is going on? Robert Burns Antibody Unit SASA Craigs Road Edinburgh EH12 8NJ burns@sasa.gov.uk --- From owner-diagnost@hgmp.mrc.ac.uk Thu Feb 17 09:16:17 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id EC89417AD0; Thu, 17 Feb 2000 09:16:16 +0000 (GMT) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 1) id 35D8217ACD; Thu, 17 Feb 2000 09:16:15 +0000 (GMT) To: diagnost@net.bio.net Newsgroups: bionet.diagnostics From: Dan@hgmp.mrc.ac.uk, Silverman@hgmp.mrc.ac.uk, [mailto:dsilver@ucla.edu]@hgmp.mrc.ac.uk Subject: Neuroimaging in Dementia Session, METBS '2000 Message-Id: <20000217091615.35D8217ACD@mercury.hgmp.mrc.ac.uk> Date: Thu, 17 Feb 2000 09:16:15 +0000 (GMT) Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk NEUROIMAGING METHODS IN EVALUATION OF DEMENTIA This Special Session of the annual METMBS '2000 meeting will bring together researchers from diverse neuroimaging backgrounds to present data, and stimulate discussion, on the current application and potential of techniques such as positron emission tomography, single photon emission computed tomography, and magnetic resonance imaging, to improve the clinical management of people beginning to experience symptoms of early dementia. ________________________________________________________________________ ___ SUBMISSION OF PAPERS Prospective participants are invited to submit a one-page abstract. Include: 1) title, 2) names and affiliations of each author, 3) body of the abstract, 4) postal address, e-mail address, and phone number of corresponding author, 5) name of presenting author, and 6) up to five keywords. Please submit by e-mail (include both attached and 'pasted-in' versions) to dsilver@ucla.edu, by 28 February 2000. ________________________________________________________________________ __ IMPORTANT DATES: 28 February 2000 (Monday): Abstracts due 3 April 2000 (Monday): Notification of acceptance 1 May 2000 (Monday): Camera-ready papers (up to 7 pages, to be published in full in Conference proceedings volume) & pre-registration due 26-29 June 2000: Annual Mathematics and Engineering Techniques in Medicine and Biological Sciences meeting (METMBS '2000), Las Vegas ________________________________________________________________________ __ For more information, contact: Daniel H. Silverman, MD, PhD Head, Neuronuclear Imaging Research Group Ahmanson Biological Imaging Clinic, CHS AR-144 University of California, Los Angeles School of Medicine Los Angeles, CA 90095-6942 dsilver@ucla.edu From owner-diagnost@hgmp.mrc.ac.uk Thu Feb 17 14:44:43 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id 5B0A217AE4; Thu, 17 Feb 2000 14:44:42 +0000 (GMT) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 1) id 6A12A17ADA; Thu, 17 Feb 2000 14:44:37 +0000 (GMT) To: diagnost@net.bio.net Newsgroups: bionet.diagnostics From: news@hgmp.mrc.ac.uk, [mailto:news@theplanet.net]@hgmp.mrc.ac.uk, On@hgmp.mrc.ac.uk, Behalf@hgmp.mrc.ac.uk, Of@hgmp.mrc.ac.uk, David@hgmp.mrc.ac.uk, A@hgmp.mrc.ac.uk, C@hgmp.mrc.ac.uk, Jones@hgmp.mrc.ac.uk Subject: Re: Antibody interactions Message-Id: <20000217144437.6A12A17ADA@mercury.hgmp.mrc.ac.uk> Date: Thu, 17 Feb 2000 14:44:37 +0000 (GMT) Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk Could the epitopes be overlapping? wrote in message news:88gdui$ipg$1@mercury.hgmp.mrc.ac.uk... > > > > -----Original Message----- > From: Robert Burns [mailto:burns@sasa.gov.uk] > Sent: 16 February 2000 11:36 > To: diagnost@net.bio.net > Subject: Antibody interactions > > > We have come across a curious phenomenon when making cocktails of > monoclonals. Two of our mab/Alk.phos conjugates which detect Potato > Virus A > pick up an isolate of this virus individually in ELISA. However when a > mixture of the two conjugates is used we cannot detect this isolate. Any > ideas of what is going on? > > > Robert Burns > > > > Antibody Unit > SASA > Craigs Road > Edinburgh > EH12 8NJ > > burns@sasa.gov.uk > > > --- From owner-diagnost@hgmp.mrc.ac.uk Fri Feb 18 09:20:28 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id 5267E17B0B; Fri, 18 Feb 2000 09:20:17 +0000 (GMT) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 1) id C4CAC17AFE; Fri, 18 Feb 2000 09:20:15 +0000 (GMT) To: diagnost@net.bio.net Newsgroups: bionet.diagnostics From: daemon@hgmp.mrc.ac.uk, [mailto:daemon@hgmp.mrc.ac.uk]@hgmp.mrc.ac.uk, On@hgmp.mrc.ac.uk, Behalf@hgmp.mrc.ac.uk, Of@hgmp.mrc.ac.uk Subject: bcl2 rearrangement Message-Id: <20000218092015.C4CAC17AFE@mercury.hgmp.mrc.ac.uk> Date: Fri, 18 Feb 2000 09:20:15 +0000 (GMT) Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk Hi we regularly assay for the t(14;18) rtanslocation which involves the bcl2 oncogene and the IgH gene. Our standard positive control is a PCR product of approximately 230bp. recently we obtained a patient sample which gave a product of over 1000 bp. My question is: how big do they get? is it possible that a false negative could be obtained for very large and possibly non amplifiable products. Is there a diagnostic significance for very large rearranged products? thanks for your help Louise ********************************************************************** This email and any files transmitted with it are confidential and intended solely for the use of the individual or entity to whom they are addressed. If you have received this email in error please notify the system manager. This footnote also confirms that this email message has been swept by MIMEsweeper for the presence of computer viruses. www.mimesweeper.com ********************************************************************** --- From owner-diagnost@hgmp.mrc.ac.uk Fri Feb 18 09:22:47 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id 8F91917B24; Fri, 18 Feb 2000 09:22:46 +0000 (GMT) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 1) id 54E0D17B0B; Fri, 18 Feb 2000 09:22:45 +0000 (GMT) To: diagnost@net.bio.net Newsgroups: bionet.diagnostics From: daemon@hgmp.mrc.ac.uk, [mailto:daemon@hgmp.mrc.ac.uk]@hgmp.mrc.ac.uk, On@hgmp.mrc.ac.uk, Behalf@hgmp.mrc.ac.uk, Of@hgmp.mrc.ac.uk Subject: Re: Antibody interactions Message-Id: <20000218092245.54E0D17B0B@mercury.hgmp.mrc.ac.uk> Date: Fri, 18 Feb 2000 09:22:45 +0000 (GMT) Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk > Could the epitopes be overlapping? Surely, at least one of the antibodies would still be able to bind. P. Crilly Bell College Hamilton p.crilly@bell.ac.uk --- From owner-diagnost@hgmp.mrc.ac.uk Fri Feb 18 15:38:49 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id CBE8617B4F; Fri, 18 Feb 2000 15:38:48 +0000 (GMT) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 1) id 74AC017A66; Fri, 18 Feb 2000 15:38:47 +0000 (GMT) To: diagnost@net.bio.net Newsgroups: bionet.diagnostics From: Krzysztof@hgmp.mrc.ac.uk, Wroblewski@hgmp.mrc.ac.uk, [mailto:krzyszto@hotmail.com]@hgmp.mrc.ac.uk Subject: Fetal Ultrasound Message-Id: <20000218153847.74AC017A66@mercury.hgmp.mrc.ac.uk> Date: Fri, 18 Feb 2000 15:38:47 +0000 (GMT) Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk Visit Fetal Echocardiography Homepage located at: http://www.med.upenn.edu/fetus This largest free library of fetal heart images contains over 100 high quality ultrasound pictures of the normal and abnormal fetal heart obtained using different ultrasound techniques: 2D-echo, Color Doppler, M-mode, and Pulse Doppler. Use the fetal calculator to compute gestational age using typical ultrasound measurements. Join the Discussion Forum. Exchange the information about fetal echocardiography, cardiology and general fetal ultrasound. Feel free to post any question or problem related to this field. If you have any interesting case, please post an URL to the site where images can be viewed, or send an e-mail to: krzyszto@mail.med.upenn.edu to arrange for the images to be publicly available. From owner-diagnost@hgmp.mrc.ac.uk Tue Feb 22 15:03:22 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id 7250417B53; Tue, 22 Feb 2000 15:03:21 +0000 (GMT) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 1) id 2C26617A82; Tue, 22 Feb 2000 15:03:19 +0000 (GMT) To: diagnost@net.bio.net Newsgroups: bionet.diagnostics From: daemon@hgmp.mrc.ac.uk, [mailto:daemon@hgmp.mrc.ac.uk]@hgmp.mrc.ac.uk, On@hgmp.mrc.ac.uk, Behalf@hgmp.mrc.ac.uk, Of@hgmp.mrc.ac.uk Subject: dgge Message-Id: <20000222150319.2C26617A82@mercury.hgmp.mrc.ac.uk> Date: Tue, 22 Feb 2000 15:03:19 +0000 (GMT) Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk i make amplification with primers that give a 700bp fragment. i had tried to make migration in 25 to 35% dénaturant gel at 75°C but for three time i had obtained no séparation and the last time there was no band. can you explain me this or can you show me a reference for this thank you --- From owner-diagnost@hgmp.mrc.ac.uk Wed Feb 23 09:49:34 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id 63F4817BA4; Wed, 23 Feb 2000 09:49:33 +0000 (GMT) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 1) id 263C217A91; Wed, 23 Feb 2000 09:49:30 +0000 (GMT) To: diagnost@net.bio.net Newsgroups: bionet.diagnostics From: news@hgmp.mrc.ac.uk, [mailto:news@theplanet.net]@hgmp.mrc.ac.uk, On@hgmp.mrc.ac.uk, Behalf@hgmp.mrc.ac.uk, Of@hgmp.mrc.ac.uk, David@hgmp.mrc.ac.uk, A@hgmp.mrc.ac.uk, C@hgmp.mrc.ac.uk, Jones@hgmp.mrc.ac.uk Subject: Re: Antibody interactions Message-Id: <20000223094930.263C217A91@mercury.hgmp.mrc.ac.uk> Date: Wed, 23 Feb 2000 09:49:30 +0000 (GMT) Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk Yea I did think of that. But isn't it also possible that they inhibit each other in some way? Robert have you any other ideas on this one? I've been out of the buisness to long! Regards Dave David A C Jones dave@dacjones.co.uk wrote in message news:88j314$nrq$1@mercury.hgmp.mrc.ac.uk... > > > > > Could the epitopes be overlapping? > > Surely, at least one of the antibodies would still be able to bind. > > P. Crilly > Bell College > Hamilton > p.crilly@bell.ac.uk > > > > --- From owner-diagnost@hgmp.mrc.ac.uk Wed Feb 23 10:19:06 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id 7B6C717BA3; Wed, 23 Feb 2000 10:19:05 +0000 (GMT) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 1) id D911217A93; Wed, 23 Feb 2000 10:19:03 +0000 (GMT) To: diagnost@net.bio.net Newsgroups: bionet.diagnostics From: daemon@hgmp.mrc.ac.uk, [mailto:daemon@hgmp.mrc.ac.uk]@hgmp.mrc.ac.uk, On@hgmp.mrc.ac.uk, Behalf@hgmp.mrc.ac.uk, Of@hgmp.mrc.ac.uk Subject: dgge Message-Id: <20000223101903.D911217A93@mercury.hgmp.mrc.ac.uk> Date: Wed, 23 Feb 2000 10:19:03 +0000 (GMT) Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk i make amplification with primers that give a 700bp fragment. i had tried to make migration in 25 to 35% dénaturant gel at 75°C but for three time i had obtained no séparation and the last time there was no band. can you explain me this or can you show me a reference for this thank you --- From owner-diagnost@hgmp.mrc.ac.uk Fri Feb 25 17:17:13 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id B61E017BFA; Fri, 25 Feb 2000 17:17:12 +0000 (GMT) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 1) id 8F50E17AC1; Fri, 25 Feb 2000 17:17:11 +0000 (GMT) To: diagnost@net.bio.net Newsgroups: bionet.diagnostics From: daemon@hgmp.mrc.ac.uk, [mailto:daemon@hgmp.mrc.ac.uk]@hgmp.mrc.ac.uk, On@hgmp.mrc.ac.uk, Behalf@hgmp.mrc.ac.uk, Of@hgmp.mrc.ac.uk Subject: METMBS 2000 Call for PApers Message-Id: <20000225171711.8F50E17AC1@mercury.hgmp.mrc.ac.uk> Date: Fri, 25 Feb 2000 17:17:11 +0000 (GMT) Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk The 2000 International Conference on Mathematics and Engineering Techniques in Medicine and Biological Sciences (METMBS'2000) June 26 - 29, 2000 Monte Carlo Resort, Las Vegas, Nevada, USA Call for Papers/Abstracts Recent advances in computer technology have provided the tools and the environment to study, analyze, and better understand complex systems. This technological development has enabled researchers to collect and analyze massive amounts of data to a scale previously not possible. The impact of this technology is now being felt in the medical field and in the biological sciences. In recent years, research in interdisciplinary areas such as Bioinformatics and computer assisted medical decision-making has dramatically intensified. METMBS'2000 aims to provide a platform for researchers to present and discuss recent breakthroughs in this area. The METMBS'2000 Conference will be held concurrently (i.e., same location and dates) with the International Conference on Parallel and Distributed Processing Techniques and Applications (PDPTA'2000), the International Conference on Imaging Science, Systems, and Technology (CISST) and the International Conference on Artificial Intelligence (IC-AI). You are invited to submit a one-page abstract or a draft paper of about 4 pages, and/or a proposal to organize a technical session (see below for submission information). All accepted submissions will be published in the conference proceedings. THE NAMES OF TECHNICAL SESSION CHAIRS WILL APPEAR AS ASSOCIATE EDITORS ON THE COVER OF THE CONFERENCE PROCEEDINGS. SCOPE Topics of interest include, but are not limited to, the following: o Bioinformatics: This includes informatics techniques in genomics gene sequencing, gene pattern discovery, gene pattern-function studies, and other genomics related studies). o Data mining in medicine and biological sciences. o Pattern recognition in medicine and biological sciences. o Signal processing in medicine and biological sciences (e.g. biomedical signal processing, etc.) o Image processing in medicine and biological sciences (e.g. biomedical image processing, biomedical imaging, etc.) o Medical decision-making. o Medical Physics. o Biomedical Engineering. o Biomedical Electronics. o Biosignal interpretation. o Any application of computers in Medicine and biological sciences (protein structure-function analysis, drug and protein design, molecular modeling and simulation, etc.) o Application of information technology in biomedicine (e.g. medical database management, information retrieval and use of computers in hospitals) o Application of Computational Intelligence (artificial neural networks, fuzzy logic, and evolutionary computing) in medicine and biological sciences o Medical and bio-computing. o Computer-based medical systems (automation in medicine, etc.) o Recent history (1990-1999) of Mathematics and engineering techniques in medicine and biological sciences, and what to expect during the next decade (2000-2009); New horizons. Review articles) o Other aspects and applications relating to technological advancements in medicine and biological sciences. SUBMISSION OF PAPERS Prospective authors are invited to submit three copies of their one-page abstract or draft paper (about 4 pages) to F. Valafar (address is given below) by February 28, 2000. E-mail and Fax submissions are also acceptable. The length of the Camera-Ready papers (if accepted) will be limited to 7 pages. Papers must not have been previously published or currently submitted for publication elsewhere. The abstract and the first page of the draft paper should include: title of the paper, name, affiliation, postal address, E-mail address, telephone number, and Fax number for each author. The first page should also include the name of the author who will be presenting the paper (if accepted) and a maximum of 5 keywords. PROPOSAL FOR ORGANIZING TECHNICAL SESSIONS Each technical session will have at least 6 paper presentations. The session chairs will be responsible for all aspects of their sessions, including soliciting papers, reviewing, selecting, ... The names of session chairs will appear as Associate Editors in the conference proceedings. After the conference, some sessions will be considered for publication in appropriate journals as Special Issues with the session proposer as the Guest Editor of the journal. Proposals to organize technical sessions should include the following information: name and address (+ E-mail) of the proposer, title of session, a 100-word description of the topic of the session, and a short description on how the session will be advertised (in most cases, session proposers solicit papers from colleagues and researchers whose work is known to the session proposer). Mail your proposal to F. Valafar (address is given below); E-mail submissions are preferred. EVALUATION PROCESS Papers will be evaluated for originality, significance, clarity, and soundness. Two researchers in the topical area will referee each paper. The Camera-Ready papers will be reviewed by one person. PUBLICATION The conference proceedings will be published by CSREA Press (ISBN). The proceedings will be available at the conference. Some accepted papers will also be considered for journal publication (soon after the conference). ORGANIZERS/SPONSORS A number of university faculty members and their staff, in cooperation with the Monte Carlo Resort (Conference Division, Las Vegas), will be organizing the conference. The conference will be sponsored by Computer Science Research, Education, & Applications Press (CSREA: USA Federal EIN # 58-2171953) in cooperation with research centers, international associations, international research groups, and developers of high-performance machines and systems. The complete list of sponsors and co-sponsors will be available at a later time. The last conference's sponsors included: CSREA, the National Supercomputing Center for Energy and the Environment - DOE, The International Association for Mathematics and Computers in Simulation, The International Technology Institute (ITI), The Java High Performance Computing research group, Korea Information Processing Society, World Scientific and Engineering Society, Sundance Digital Signal Processing Inc., the Computer Vision Research and Applications Tech., and more. LOCATION OF CONFERENCE The conference will be held in the Monte Carlo Resort Hotel, Las Vegas, Nevada, USA. This is a mega hotel with excellent conference facilities and over 3000 rooms. The hotel is minutes from the Las Vegas airport with free shuttles to and from the airport. This hotel has many vacation and recreational attractions, including: waterfalls, casino, spa, pools & kiddie pools, sunning decks, Easy River water ride, wave pool with cascades, lighted tennis courts, health spa (with workout equipment, whirlpool, sauna,...), arcade virtual reality game rooms, nightly shows, snack bars, a number of restaurants, shopping area, bars, ... Many of these attractions are open 24 hours a day and most are suitable for families and children. The negotiated hotel's room rate for conference attendees is very reasonable ($79 + tax) per night (no extra charge for double occupancy) for the duration of the conference. The hotel is within walking distance from most other Las Vegas attractions (major shopping areas, recreational destinations, fine dining and night clubs, free street shows, and more). For the benefit of our international colleagues: the state of Nevada neighbors with the states of California, Oregon, Idaho, Utah, and Arizona. Las Vegas is only a few driving hours away from other major cities and attractions, including: Los Angeles, San Diego, Phoenix, the Grand Canyon, and more. EXHIBITION An exhibit is planned for the duration of the conference. We have reserved 20+ exhibit spaces. Interested parties should contact F. Valafar (address is given below). All exhibitors will be considered to be the co-sponsors of the conference. IMPORTANT DATES February 28, 2000 (Monday): One-page Abstracts or Draft papers (about 4 pages) due April 3, 2000 (Monday): Notification of acceptance May 1, 2000 (Monday): Camera-Ready papers & Preregistration due June 26 - 29, 2000: METMBS'2000 Conference Proposals to organize technical sessions should be submitted as soon as possible. All accepted papers are expected to be presented at the conference. MEMBERS OF PROGRAM & ORGANIZING COMMITTEES The Program Committee is currently being formed. Those interested in joining the Program Committee should e-mail F. Valafar (faramarz@cns.bu.edu ) the following information: Name, affiliation and position, complete mailing address, e-mail address, tel/fax numbers, a short biography together with research interests. OTHER INFORMATION Last year PDPTA, CISST, and IC-AI had research contributions from over 44 countries (over 900 participants from all over the world.) To make this a more complete suite of conferences, we have added METMBS. METMBS will also have a strong international flavor and offers its participants an introduction to a wide range of related interdisciplinary subjects through the other three conferences. CONFERENCE CONTACT: Faramarz Valafar Cognitive and Neural Systems Boston University 677 Beacon Street Boston, MA 02215 Tel: (617) 353-5134 Fax: (617) 353-7755 E-mail: Faramarz@cns.bu.edu --- From owner-diagnost@hgmp.mrc.ac.uk Mon Feb 28 08:48:12 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id A24ED17AA9; Mon, 28 Feb 2000 08:48:11 +0000 (GMT) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 1) id 6445B17A94; Mon, 28 Feb 2000 08:48:10 +0000 (GMT) To: diagnost@net.bio.net Newsgroups: bionet.diagnostics From: Bert@hgmp.mrc.ac.uk, Gold@hgmp.mrc.ac.uk, [mailto:bgold@ktb.net]@hgmp.mrc.ac.uk Subject: Re: bcl2 rearrangement Message-Id: <20000228084810.6445B17A94@mercury.hgmp.mrc.ac.uk> Date: Mon, 28 Feb 2000 08:48:10 +0000 (GMT) Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk There are major and minor breakpoints at this locus. The rearrangement involves slippage along some Alu (repetitive) DNA in the heavy chain gene. You should read the literature. There are also indications that normal individuals contain a small percentage of cells which rearrange. PNAS paper around 1994-95 if I remember correctly. So you need to really, really know what you are looking for at this locus before coming to any conclusions. Good luck. Bert Gold, Ph.D. Sherman Oaks, California daemon@hgmp.mrc.ac.uk, [mailto:daemon@hgmp.mrc.ac.uk], On, Behalf, Of wrote: > > Hi > > we regularly assay for the t(14;18) rtanslocation which involves the > bcl2 oncogene and the IgH gene. Our standard positive control is a PCR From owner-diagnost@hgmp.mrc.ac.uk Mon Feb 28 13:52:44 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id 9045017AFD; Mon, 28 Feb 2000 13:52:41 +0000 (GMT) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 1) id 5A61117AF5; Mon, 28 Feb 2000 13:52:27 +0000 (GMT) To: diagnost@net.bio.net Newsgroups: bionet.diagnostics From: daemon@hgmp.mrc.ac.uk, [mailto:daemon@hgmp.mrc.ac.uk]@hgmp.mrc.ac.uk, On@hgmp.mrc.ac.uk, Behalf@hgmp.mrc.ac.uk, Of@hgmp.mrc.ac.uk Subject: selectscience Message-Id: <20000228135227.5A61117AF5@mercury.hgmp.mrc.ac.uk> Date: Mon, 28 Feb 2000 13:52:27 +0000 (GMT) Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk Did you know that there is a website dedicated to the science industry and its consumers? Select Science is consumer based Web site, which not only provides information on companies and their products, it also has comments about those products written by the people who use them every day. There are also searchable jobs and conference data bases and the latest industry news, as well as articles written by various scientists. The good news is that you can access and contribute FREE of CHARGE Mandi Keet Managing Editor, www.selectscience.net ---